| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shapiro SS et al. | Synthetic progestins: in vitro potency on human endometrium and specific binding to cytosol receptor. | 1978 | Am. J. Obstet. Gynecol. | pmid:717455 |
| Avoidance of dual publication. Statement by the Council of Biology Editors. | 1973 | Am. J. Obstet. Gynecol. | pmid:4681830 | |
| Taymor ML and Rizkallah TH | Progestogen-estrogen therapy in the menopause. A double blind study. | 1967 | Am. J. Obstet. Gynecol. | pmid:6016347 |
| Hulka JF and Mohr K | Interference of cortisone-induced homograft survival by progestins. | 1967 | Am. J. Obstet. Gynecol. | pmid:5334310 |
| Levin JH et al. | Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells. | 1990 | Am. J. Obstet. Gynecol. | pmid:2147816 |
| Dove DJ | Chorea associated with oral contraceptive therapy. | 1980 | Am. J. Obstet. Gynecol. | pmid:7395941 |
| Bonnar J | Coagulation effects of oral contraception. | 1987 | Am. J. Obstet. Gynecol. | pmid:2960241 |
| Hall WD et al. | Blood pressure and oral progestational agents. A prospective study of 119 black women. | 1980 | Am. J. Obstet. Gynecol. | pmid:7352524 |
| Mink IB et al. | Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy. | 1974 | Am. J. Obstet. Gynecol. | pmid:4275088 |
| LEACH RB and MARGULIS RR | INHIBITION OF ADRENOCORTICAL RESPONSIVENESS DURING PROGESTIN THERAPY. | 1965 | Am. J. Obstet. Gynecol. | pmid:14310030 |
| Ansari AH and Beck PR | Pituitary-adrenocortical effect of short- and long-term progestational therapy. | 1969 | Am. J. Obstet. Gynecol. | pmid:4179212 |
| Beck LR et al. | New long-acting injectable microcapsule contraceptive system. | 1979 | Am. J. Obstet. Gynecol. | pmid:114054 |
| Bowman JA | The effect of norethindrone-mestranol on cervical mucus. | 1968 | Am. J. Obstet. Gynecol. | pmid:5724391 |
| Murphy AA et al. | The effect of tetracycline on levels of oral contraceptives. | 1991 | Am. J. Obstet. Gynecol. | pmid:1986620 |
| Gossain VV et al. | Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels. | 1983 | Am. J. Obstet. Gynecol. | pmid:6356926 |
| Moore DE et al. | An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol. | 1978 | Am. J. Obstet. Gynecol. | pmid:204191 |
| Andersen RN et al. | Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease. | 1976 | Am. J. Obstet. Gynecol. | pmid:944533 |
| Sørensen MB et al. | Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement. | 2001 | Am. J. Obstet. Gynecol. | pmid:11174477 |
| Higham JM and Shaw RW | A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. | 1993 | Am. J. Obstet. Gynecol. | pmid:8238173 |
| Young RL et al. | A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. | 1992 | Am. J. Obstet. Gynecol. | pmid:1530022 |
| Kojima T et al. | Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. | 1993 | Am. J. Obstet. Gynecol. | pmid:8267059 |
| Darney PD | Hormonal implants: contraception for a new century. | 1994 | Am. J. Obstet. Gynecol. | pmid:8178903 |
| Ambrus JL et al. | Progestational agents and blood coagulation. VII. Thromboembolic and other complications of oral contraceptive therapy in relationship to pretreatment levels of blood coagulation factors: summary report of a ten-year study. | 1976 | Am. J. Obstet. Gynecol. | pmid:133615 |
| Martin PL et al. | Graded sequential therapy in the menopause: a double-blind study. | 1971 | Am. J. Obstet. Gynecol. | pmid:4938602 |
| Dören M et al. | Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. | 1995 | Am. J. Obstet. Gynecol. | pmid:7503183 |
| Vanin CM et al. | Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate. | 1995 | Am. J. Obstet. Gynecol. | pmid:7503190 |
| Roy S et al. | Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. | 1980 | Am. J. Obstet. Gynecol. | pmid:6767404 |
| Goldzieher JW et al. | Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study. | 1971 | Am. J. Obstet. Gynecol. | pmid:4108553 |
| Kjos SL et al. | Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. | 1990 | Am. J. Obstet. Gynecol. | pmid:2256489 |
| Tsai CC et al. | Low-dose oral contraception and blood pressure in women with a past history of elevated blood pressure. | 1985 | Am. J. Obstet. Gynecol. | pmid:3966503 |
| Hammerstein J | Prodrugs: advantage or disadvantage? | 1990 | Am. J. Obstet. Gynecol. | pmid:2256526 |
| Gillmer MD | Progestogen potency in oral contraceptive pills. | 1987 | Am. J. Obstet. Gynecol. | pmid:3118717 |
| Hale RW | Phasic approach to oral contraceptives. | 1987 | Am. J. Obstet. Gynecol. | pmid:3118718 |
| Dooley RR et al. | Polypoid cervicitis in cystic fibrosis patients receiving oral contraceptives. | 1974 | Am. J. Obstet. Gynecol. | pmid:4818428 |
| Doyle LL | Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats. | 1975 | Am. J. Obstet. Gynecol. | pmid:1115155 |
| Suparto IH et al. | Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys. | 2003 | Am. J. Obstet. Gynecol. | pmid:12748457 |
| Kharma K et al. | Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol. | 1972 | Am. J. Obstet. Gynecol. | pmid:4110418 |
| Zussman WV et al. | Ovarian morphology following cyclic norethindrone-mestranol therapy. | 1967 | Am. J. Obstet. Gynecol. | pmid:6034978 |
| Williams SR et al. | A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. | 1990 | Am. J. Obstet. Gynecol. | pmid:2309827 |
| Dickey RP et al. | Estrogen potencies of three new low-dose oral contraceptives. | 1976 | Am. J. Obstet. Gynecol. | pmid:941952 |
| Check JH et al. | Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. | 1989 | Am. J. Obstet. Gynecol. | pmid:2492146 |
| Board JA | Continuous norethindrone, 0.35 mg., as an oral contraceptive agent. | 1971 | Am. J. Obstet. Gynecol. | pmid:5100077 |
| Aune B et al. | Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood--a beneficial effect on atherogenesis and thrombus formation? | 1995 | Am. J. Obstet. Gynecol. | pmid:8610768 |
| Pirroinen O and Rauramo L | Oral conception and uterine size-ultrasonic study. | 1975 | Am. J. Obstet. Gynecol. | pmid:1130457 |
| Vorherr H | Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. | 1986 | Am. J. Obstet. Gynecol. | pmid:3511705 |
| Bergink W et al. | Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. | 1990 | Am. J. Obstet. Gynecol. | pmid:2147817 |
| Beck RP et al. | Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol. | 1972 | Am. J. Obstet. Gynecol. | pmid:5060381 |
| Douglas Ringrose CA et al. | The effects of the administration and subsequent withdrawal of norethindrone and mestranol (Ortho-Novum) therapy on egg production in the chicken. | 1966 | Am. J. Obstet. Gynecol. | pmid:5948252 |
| Björn I et al. | Negative mood changes during hormone replacement therapy: a comparison between two progestogens. | 2000 | Am. J. Obstet. Gynecol. | pmid:11120505 |
| Rifkin I et al. | Amenorrhea following use of oral contraceptives. | 1972 | Am. J. Obstet. Gynecol. | pmid:4678381 |